The prevalence of factor VIII inhibitors and genetic aspects of inhibitor development in Chinese patients with haemophilia A
- 21 June 2010
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 16 (4), 632-639
- https://doi.org/10.1111/j.1365-2516.2010.02211.x
Abstract
Summary. The prevalence of inhibitors in Chinese haemophiliacs has not yet been reported. The aim of this study was to identify the prevalence of factor VIII (FVIII) inhibitors among haemophiliacs who are treated only with plasma‐derived FVIII (pdFVIII), cryoprecipitate or fresh frozen plasma (FFP), and tried to explore the relationship between the generation of inhibitors and particular FVIII deficiency genotypes. Clinical information and blood samples of 1435 patients with haemophilia A (HA) were collected by six haemophilia centres in China. The Nijmegen modification of the Bethesda assay was used to detect inhibitors. Multiplex PCR, long‐range PCR and direct sequencing were performed for genotyping. The overall prevalence of inhibitors in Chinese HA patients was 3.9% and the prevalence of severe haemophiliacs was 4.3%; 18 of the 56 patients with inhibitors had high titres. A total of 38 different mutations were identified in the 55 patients with inhibitors, including 15 intron 22 and 3 intron 1 inversions, seven large deletions, 14 small deletion/insertions, seven nonsense mutations, one splice site mutations and eight missense mutations. Of 38 mutations, 28 were novel. Patients with large deletions and nonsense mutations were prone to have high titre inhibitors, with incidence rates of 57.1% (4/7) and 42.9% (3/7), respectively. In conclusion, the prevalence of inhibitors in Chinese HA patients is much lower than that reported for other ethnic groups and the large deletion and nonsense mutations are high risk factors for high titre inhibitor development.Keywords
This publication has 20 references indexed in Scilit:
- Inhibitor development in one patient and laboratory discrepancies in several families with both mild haemophilia and Arg531Cys mutationHaemophilia, 2007
- Immunological aspects of inhibitor developmentHaemophilia, 2006
- The epidemiology of inhibitors in haemophilia A: a systematic reviewHaemophilia, 2003
- Inhibitor development in correlation to factor VIII genotypesHaemophilia, 2002
- Treatment of haemophilia in the United Kingdom 1981-1996Haemophilia, 2001
- Factor VIII Inhibitors in Patients with Hemophilia AActa Haematologica, 1999
- Factor VIII inhibitors in haemophiliacs: a single-centre experience over 34 years, 1964-97British Journal of Haematology, 1999
- Inversions disrupting the factor VIII gene are a common cause of severe haemophilia ANature Genetics, 1993
- The Mode of Action of Antibodies which Destroy Factor VIII.British Journal of Haematology, 1972
- The Mode of Action of Antibodies which Destroy Factor VIII.British Journal of Haematology, 1972